Amyloid-beta clearance in Alzheimer's disease
Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer's disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogene...
Saved in:
Main Author: | Robert Marr (auth) |
---|---|
Other Authors: | Eliezer Masliah (auth) |
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Frontiers Media SA
2015
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Infectious Origin of Alzheimer's Disease: An End for This Devastating Disorder?
Published: (2020) -
The Alzheimer's Disease Challenge
Published: (2019) -
The Physiological Functions of the Amyloid Precursor Protein Gene Family
by: Ulrike C. Muller
Published: (2017) -
Amyloid-β Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases
Published: (2023) -
Amyloid-β
Published: (2023)